Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRSP Net Margin

The Net Margin of CRISPR Therapeutics AG (CRSP) is -981.54%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

CRSP Net Margin - Historical Value
Date Value
2024-12-31 -981.54%
2023-12-31 -41.38%
2022-12-31 -54183.33%
2021-12-31 41.28%
2020-12-31 -49842.86%
2019-12-31 23.10%
2018-12-31 -5322.58%
2017-12-31 -166.83%
2016-12-31 -446.15%
2015-12-31 -12750.00%
CRSP Net Margin - Peers Comparison